Spyre Therapeutics, Inc.
SYRE
11 insider filings · Latest: May 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 8, 2026 | May 9 1:31 AM | Michael Thomas HendersonDirector | Sale | 80,000 | $74.40 | $6.0M | 88,606(D) | View → |
| May 8, 2026 | May 8 8:22 PM | MICHAEL HENDERSON | Proposed Sale | 80,000 | $73.10 | $5.8M | — | View → |
| May 1, 2026 | May 2 1:35 AM | Scott L BurrowsChief Financial Officer | Sale | 12,500 | $71.37 | $892.1K | 97,994(D) | View → |
| May 1, 2026 | May 2 1:34 AM | Sheldon SloanChief Medical Officer | Sale | 78,333 | $71.50 | $5.6M | 0(D) | View → |
| May 1, 2026 | May 2 1:34 AM | Cameron TurtleDirector, Chief Executive Officer | Sale | 15,000 | $71.37 | $1.1M | 612,540(D) | View → |
| May 1, 2026 | May 1 8:44 PM | SHELDON SLOAN | Proposed Sale | 78,333 | $74.45 | $5.8M | — | View → |
| May 1, 2026 | May 1 8:44 PM | SCOTT BURROWS | Proposed Sale | 27,500 | $74.45 | $2.0M | — | View → |
| Apr 1, 2026 | Apr 4 1:30 AM | Cameron TurtleDirector, Chief Executive Officer | Sale | 15,000 | $49.33 | $739.9K | 627,540(D) | View → |
| Apr 1, 2026 | Apr 4 1:30 AM | Sheldon SloanChief Medical Officer | Sale | 7,958 | $50.00 | $397.9K | 0(D) | View → |
| Apr 1, 2026 | Apr 4 1:29 AM | Scott L BurrowsChief Financial Officer | Sale | 7,500 | $49.34 | $370.1K | 97,994(D) | View → |
| Apr 1, 2026 | Apr 1 8:38 PM | SHELDON SLOAN | Proposed Sale | 7,958 | $50.44 | $401.4K | — | View → |
| Mar 3, 2026 | Mar 4 2:32 AM | Scott L BurrowsChief Financial Officer | Sale | 2,500 | $40.65 | $101.6K | 97,994(D) | View → |
| Mar 2, 2026 | Mar 4 2:31 AM | Cameron TurtleDirector, Chief Executive Officer | Sale | 15,000 | $42.19 | $632.9K | 642,540(D) | View → |
| Mar 3, 2026 | Mar 3 9:43 PM | SCOTT BURROWS | Proposed Sale | 10,000 | $42.49 | $424.9K | — | View → |
| Mar 2, 2026 | Mar 2 9:31 PM | CAMERON TURTLE | Proposed Sale | 60,000 | $43.01 | $2.6M | — | View → |
| Feb 2, 2026 | Feb 5 2:33 AM | Cameron TurtleDirector, Chief Executive Officer | Sale | 15,000 | $32.80 | $492.0K | 657,540(D) | View → |
| Nov 3, 2025 | Nov 3 9:24 PM | CAMERON TURTLE | Proposed Sale | 90,000 | $24.46 | $2.2M | — | View → |
| Oct 25, 2024 | Oct 25 8:28 PM | SESSIONS, LLC | Proposed Sale | 7,000 | $33.70 | $235.9K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | May 2 1:35 AM | Scott L BurrowsChief Financial Officer | Option Exercise | 12,500 | $14.50 | 382,357(D) | View → |
| May 1, 2026 | May 2 1:34 AM | Sheldon SloanChief Medical Officer | Option Exercise | 78,333 | $27.46 | 321,667(D) | View → |
| Apr 1, 2026 | Apr 4 1:30 AM | Sheldon SloanChief Medical Officer | Option Exercise | 7,958 | $21.66 | 87,542(D) | View → |
| Apr 1, 2026 | Apr 4 1:29 AM | Scott L BurrowsChief Financial Officer | Option Exercise | 7,500 | $14.50 | 394,857(D) | View → |
| Mar 3, 2026 | Mar 4 2:32 AM | Scott L BurrowsChief Financial Officer | Option Exercise | 2,500 | $14.50 | 402,357(D) | View → |